We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Acupuncture for the Treatment of Post-Traumatic Stress Disorder (PTSD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00055354
Recruitment Status : Completed
First Posted : February 27, 2003
Last Update Posted : August 18, 2006
Information provided by:

February 26, 2003
February 27, 2003
August 18, 2006
September 2002
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00055354 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Acupuncture for the Treatment of Post-Traumatic Stress Disorder (PTSD)
Acupuncture Diagnosis and Treatment of DSM-IV PTSD
The purpose of this study is to evaluate acupuncture as a treatment for Post-Traumatic Stress Disorder (PTSD) and to correlate the diagnosis of PTSD with Traditional Chinese Medicine (TCM) diagnostic patterns.

This study will evaluate: 1) the TCM diagnostic differentiation patterns of people who have PTSD as defined by the Diagnostic and Statistical Manual, 4th edition; 2) if an acupuncture treatment approach is acceptable to people with PTSD; and 3) if an acupuncture treatment approach is associated with a reduction in PTSD symptoms that is comparable to that of standard treatments. Because symptoms of depression, insomnia, and pain are often associated with PTSD, we will also evaluate the potential benefit of an acupuncture approach to depression, insomnia, and pain symptoms in people with PTSD.

Patients in this study will be randomized to one of three groups. Group A will receive acupuncture therapy. Group B will receive standard Cognitive Behavior Therapy. Group C is a control group and will receive no treatment. Patients in Groups A and B will undergo a total of 24 hours of therapy over the 3 month study course. All patients will have five nontherapeutic study visits; these visits will address diagnosis and assessment. Study visits will include assessments of PTSD symptoms, sleep symptoms, and level of impairment.

Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Stress Disorders, Post-Traumatic
  • Procedure: Acupuncture
  • Behavioral: Cognitive Behavioral Therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
May 2004
Not Provided

Inclusion Criteria

  • DSM-IV diagnosis of PTSD
  • Stage I PTSD symptoms
  • PTSD Symptom Scale-Self Report (PSS-SR) score > 16
  • Meets PSS-SR diagnostic criteria

Exclusion Criteria

  • Stage I substance abuse and/or dependence in the past 6 months
  • Psychotic disorder
  • Inability to commit to treatment or wait-list conditions
  • Current treatment specifically for PTSD
  • Certain medical conditions, including thyroid disease, class IV heart failure, active cancer treatment, and uncontrolled diabetes
  • Pregnant
  • Use of benzodiazepines, narcotics, opiates, narcotic antagonists, sleep medication, muscle relaxants, analgesics, or sedatives.
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
United States
R21AT001229-01( U.S. NIH Grant/Contract )
Not Provided
Not Provided
Not Provided
Not Provided
National Center for Complementary and Integrative Health (NCCIH)
Not Provided
Not Provided
National Center for Complementary and Integrative Health (NCCIH)
July 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP